WebJan 2, 2024 · Press Releases. February 14, 2024. Halda Therapeutics unveils its first pipeline data for RIPTAC™ therapeutics, a new drug modality, at ASCO GU Symposium. January 2, 2024. Halda Therapeutics announces publication of data demonstrating proof-of-mechanism of RIPTAC™ therapeutics, a novel drug modality for treatment of cancer. WebHalda unveils its first pipeline data for RIPTAC™ therapeutics, a new drug modality, at ASCO #GU23 Symposium. Preclinical data for a prostate cancer… Liked by Kelli Jones
Contact Us - Halda TherapeuticsHalda Therapeutics
WebRob serves as Chairman of P2 Science, is a board member of Allyx Therapeutics, and is Elm Street’s observer on the board of Halda Therapeutics. Rob previously served as a board member of AxioMx, SeeClickFix, ShareGrove, and Retail Optimization Inc., and as an observer on the boards of Affomix Corporation, Arvinas, Device42, and Metagenomix. WebFeb 14, 2024 · Halda says its drug candidates are designed to hold two proteins together to cause killing of the cancer cell, an approach that could address some limitations of targeted cancer treatments. Halda is backed with $76 million from investors, including Canaan Partners and Access Biotechnology, and has two medicines in early development for … thulythads
Our Science - Halda TherapeuticsHalda Therapeutics
WebContact the Business Development Team. Image. Disclose your idea with Yale Ventures. Programs. Explore Innovation & Entrepreneurship Resources. Programs. IP Insights. ... Halda Therapeutics OpCo, Inc. Halda Therapeutics logo.jpg. Image. Helping develop innovations that impact the world’s greatest challenges. Social Links. Footer. Featured ... WebHALDA THERAPEUTICS. 115 Munson Street, Suite 101, New Haven, CT 06511. Phone: 475-210-0212 Email: [email protected] WebHalda Therapeutics. Halda Therapeutics, LLC (Branford, CT) Halda is pursuing biological drug development based on the research and ideas of Craig Crews, Yale professor and founder of Arvinas (NASDAQ: ARVN) and co-founder of Proteolix (developer of Kyprolis®, sold to Onyx, which was acquired by Amgen). Elm Street Ventures participated in a ... thuly arnaud